Table 3.

Continuous variables of immunity associated with OI incidence in the first 100 days. Measurements in the “Day +50”= group.

Variable	Median Value For Patients with OI	Median Value For Patients without OI	Logistic Regression (P-value)
Abs # CD4+ T Cells (cell # /μl)	44	137	0.02 without age in model
% CD8+ T Cells	44	14	<0.0001
% CD57+/CD28−/CD8+ T cells	9	3	<0.02
% CD25+/CD3+T Cells	22	40	<0.016
% TCRγδ T cell subset	2.3	0.97	<0.017
% ‘activated’ HLA-DR+ T cells	53	38	<0.009
% ‘NKT’ CD3+/CD56+ T cells	8	4	<0.01
% IFNγ Secreting T cells	18	4	<0.006

Confounders tested: Race, age, gender, weight, CMV status, HLA mismatch, malignancy, TBI, GvHD, High Dose steroid pulse (yes, no), Anti-CD25/Daclizumab pulse (yes, no), infused total cell dose/kg, CD34+ cell/kg, CD3+ T cell dose/kg.

OI, opportunistic infection.